http://www.catalystbiosciences.com
Catalyst Biosciences, Inc. Company Intro
Catalyst is a clinical-stage biopharmaceutical company leveraging exceptional science to discover and develop essential medicines.
Industry
Healthcare
Catalyst Biosciences, Inc. Headquaters
611 Gateway Boulevard
South San Francisco,94080
United States
Catalyst Biosciences, Inc. Share price
27 Oct 2020 01:17 GMT
$5.37
-0.13 (-2.36 %)
Catalyst Biosciences, Inc. Market cap
$126.2 M
WMC RANKING
2020
Catalyst Biosciences, Inc. # 134
BiotechnologyLatest Catalyst Biosciences, Inc. News
26 Oct 2020
Tourette Syndrome Drug Market Growth Rate By Key Vendors ...
Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc, Reviva Pharmaceuticals Inc, Synchroneuron Inc, ...
26 Oct 2020
Tourette Syndrome Drug Market 2020: Key Growth Factors and Opportunity Analysis by 2027 | Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc
Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc, Reviva Pharmaceuticals Inc, Synchroneuron ...
26 Oct 2020
Adverum Biotechnologies (ADVM) Receives a Buy from ...
The company's shares closed last Monday at $11.78. ... focusing on stocks such as Axovant Gene Therapies, Taysha Gene Therapies, and Catalyst Biosciences.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Catalyst Biosciences, Inc. | 0.33 | 1.10 | 0.96 | 0 | 0 | 0 | 1.57 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.26 | 100 | 18 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.09 | 25 | 0 | 0 | 98.33 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.80 |
| Incyte Corporation | 40.27 | 14.26 | 7.21 | 100 | 0 | 0 | 92.34 |
Catalyst Biosciences, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Catalyst Biosciences, Inc. | $18,024 | $61,415 | $-47,617 | $121.346M | 134 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.654B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.11B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.42B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.615B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Catalyst Biosciences, Inc. Social Followers vs Top 4 Industry Competitors
Catalyst Biosciences, Inc. Post vs Top 4 Industry Competitors
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
